Home > Resources > Videos > Theme 12: Pharmacovigilance in 2015 - Poised for convergence of innovation

Theme 12: Pharmacovigilance in 2015 - Poised for convergence of innovation

The 2010 European Pharmacovigilance Legislation has converted many of the concepts and approaches of pharmacovigilance into practical applications. Whilst refinement of this process continues, it already provides a system that promotes patient safety whilst remaining proportionate. This theme reviews the important learnings in pharmacovigilance to date, and what role it plays in stimulating innovation. It will examine which principles and technologies are driving change. How should these new insights and new approaches affect the way we consider risk – benefit? Should risk – benefit be applied in the same way for new and established treatments.

Spotlight

Mundipharma International Limited

Mundipharma International and the Mundipharma independent associated companies are passionately committed to improving the health and quality of life of people everywhere. Over the past 50 years the network of independent associated companies has become a leader in pain management, and through a shared spirit of innovation is building a growing presence in the oncology, rheumatoid arthritis and respiratory markets.

OTHER VIDEOS

The Cardinal Health™ InteLogix™ Platform

video | September 6, 2023

Learn about the industry’s first pharmaceutical supply chain solution that is reducing the cost of care and ensuring access to critical medications for hospitals and health systems....

Watch Now

Aeris: Benchtop XRD for pharmaceutical solid form analysis

video | August 28, 2023

Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of your solid form following processing?...

Watch Now

Semi-automated testing of on-body delivery systems (OBDS)

video | August 17, 2023

Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS)....

Watch Now

Line Optimizer - digital guided workflows for optimized pharma production operations

video | May 26, 2023

Connectivity in general is becoming an ever more important consideration for production facilities as we endeavour to produce more with less and all the while trying to satisfy an increasing need for more information and communication to and from the production equipment itself....

Watch Now

The Cardinal Health™ InteLogix™ Platform

video | September 6, 2023

Learn about the industry’s first pharmaceutical supply chain solution that is reducing the cost of care and ensuring access to critical medications for hospitals and health systems....

Watch Now

Aeris: Benchtop XRD for pharmaceutical solid form analysis

video | August 28, 2023

Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of your solid form following processing?...

Watch Now

Semi-automated testing of on-body delivery systems (OBDS)

video | August 17, 2023

Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS)....

Watch Now

Line Optimizer - digital guided workflows for optimized pharma production operations

video | May 26, 2023

Connectivity in general is becoming an ever more important consideration for production facilities as we endeavour to produce more with less and all the while trying to satisfy an increasing need for more information and communication to and from the production equipment itself....

Watch Now
MORE VIDEOS

Spotlight

Mundipharma International Limited

Mundipharma International and the Mundipharma independent associated companies are passionately committed to improving the health and quality of life of people everywhere. Over the past 50 years the network of independent associated companies has become a leader in pain management, and through a shared spirit of innovation is building a growing presence in the oncology, rheumatoid arthritis and respiratory markets.

Events